MedTrace Logo

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan

NCT06293833 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2024-03-05

No results posted yet for this study

Summary

The goal of this clinical trial is to implement lung cancer screening in a targeted high-risk population of heavy (ex-)smokers in Flanders (Belgium). This implementation study will investigate the participation rate of eligible high risk (ex-)smokers in the First Line Zone South East Region of Antwerp (ZORA) in a LDCT screening program, combined with smoking cessation.

Conditions

  • Lung Cancer, Nonsmall Cell
  • Lung Cancer
  • Smoking Cessation
  • Lung Cancer, Small Cell

Interventions

RADIATION

Low-dose CT scan

Participants get an annual low-dose CT scan in UZA

BEHAVIORAL

Smoking Cessation

Smoking cessation campagnes

Sponsors & Collaborators

  • Universiteit Antwerpen

    collaborator OTHER

  • Belgian Cancer Registry

    collaborator OTHER

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Annemiek Snoeckx, MD, PhD · University Hospital, Antwerp

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06293833 on ClinicalTrials.gov